Phase 2 Study of Bexxar in Relapsed/Refractory DLCL - Test2 - elhamkhani - TriplyDB

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

http://www.wikidata.org/entity/Q61918093

about

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

http://www.wikidata.org/entity/Q61918093

description

clinical trial

@en

klinisch onderzoek

@nl

name

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

@en

type

label

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

@en

prefLabel

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

@en

P1050

Q61918093-FC204454-ACAA-4423-8417-1C22A800F0E5

P1132

Q61918093-61853933-4898-4744-AB39-41EC7AB2135D

P1476

Q61918093-81E4D59E-7D97-4B98-AF7A-B6EC118239CF

P17

Q61918093-9562F26F-6A82-4C22-A6B2-DA15DFC62D8C

P2899

Q61918093-6AB8AFBF-A01A-4AEA-AB5D-A0C9F880DE7B

P3098

Q61918093-D05DC3D6-F2BC-42DA-AFF1-FB485BA0CB20

P31

Q61918093-530E6CE2-8F39-44B3-BBA7-B3F092CF2C45

P4844

Q61918093-379E883B-BBB2-4BDC-86DD-D57460CA4C5F

Q61918093-555CDF9F-D7C4-4606-A3A5-C6F5298CE6B6

Q61918093-C5D374F0-439B-4F9E-99F3-FCC1954593FD

P580

Q61918093-34556555-1E3C-41B4-B77D-1FC4EE9D2717

P582

Q61918093-E098DF72-379F-4AA4-8E9D-B79A846BABBA

P6099

Q61918093-602C0441-B349-4597-9F09-330974366181

P8005

Q61918093-B6D730B6-F242-4495-AAB1-FE66F0E4C490

P1050

P1132

9

http://www.w3.org/2001/XMLSchema#decimal

P1476

Phase 2 Study of Bexxar in Relapsed/Refractory Diffuse Large Cell Lymphoma (DLCL)

@en

P17

Ameeriga Ütisriigiq

P2899

19

http://www.w3.org/2001/XMLSchema#decimal

P3098

NCT00490009

http://www.w3.org/2001/XMLSchema#string

P31

P4844

diphenhydramine

P580

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P582

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6099

phase II clinical trial

P8005